AIT Austrian Institute of Technology GmbH, Center for Health and Bioresources, 3430 Tulln, Austria.
Sensors (Basel). 2017 Jan 29;17(2):256. doi: 10.3390/s17020256.
Protein microarrays represent a powerful technology with the potential to serve as tools for the detection of a broad range of analytes in numerous applications such as diagnostics, drug development, food safety, and environmental monitoring. Key features of analytical protein microarrays include high throughput and relatively low costs due to minimal reagent consumption, multiplexing, fast kinetics and hence measurements, and the possibility of functional integration. So far, especially fundamental studies in molecular and cell biology have been conducted using protein microarrays, while the potential for clinical, notably point-of-care applications is not yet fully utilized. The question arises what features have to be implemented and what improvements have to be made in order to fully exploit the technology. In the past we have identified various obstacles that have to be overcome in order to promote protein microarray technology in the diagnostic field. Issues that need significant improvement to make the technology more attractive for the diagnostic market are for instance: too low sensitivity and deficiency in reproducibility, inadequate analysis time, lack of high-quality antibodies and validated reagents, lack of automation and portable instruments, and cost of instruments necessary for chip production and read-out. The scope of the paper at hand is to review approaches to solve these problems.
蛋白质微阵列是一种强大的技术,具有作为多种应用(如诊断、药物开发、食品安全和环境监测)中广泛分析物检测工具的潜力。分析用蛋白质微阵列的主要特点包括高通量和相对较低的成本,这归因于最小试剂消耗、多重检测、快速动力学和因此的测量,以及功能集成的可能性。到目前为止,蛋白质微阵列主要用于分子和细胞生物学的基础研究,而其在临床,特别是即时护理应用方面的潜力尚未得到充分利用。问题是为了充分利用这项技术,必须实现哪些功能,必须进行哪些改进。过去,我们已经确定了在促进蛋白质微阵列技术在诊断领域应用方面需要克服的各种障碍。为了使该技术对诊断市场更具吸引力,需要显著改进的问题有:灵敏度太低和重现性不足、分析时间不足、缺乏高质量的抗体和经过验证的试剂、缺乏自动化和便携式仪器,以及芯片生产和读出所需仪器的成本。本文的范围是回顾解决这些问题的方法。